Halopemide (Standard)
Halopemide (Standard) is the analytical standard of Halopemide. This product is intended for research and analytical applications. Halopemide is a potent phospholipase D (PLD) inhibitor, with IC50s of 220 and 310 nM for human PLD1 and PLD2, respectively. Halopemid is a dopamine receptors antagonist, and acts a psychotropic agent[1][2].
Product Specifications
CAS Number
59831-65-1
UNSPSC
12352100
Target
Dopamine Receptor; Phospholipase; Reference Standards
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling; Others
Field of Research
Cancer; Neurological Disease
Smiles
O=C(C1=CC=C(C=C1)F)NCCN2CCC(CC2)N3C4=CC=C(C=C4NC3=O)Cl
Molecular Formula
C21H22ClFN4O2
Molecular Weight
416.88
References & Citations
[1]Scott SA, et al. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol. 2009 Feb;5 (2) :108-17.|[2]Neale R, et al. Acute dyskinesias in monkeys elicited by halopemide, mezilamine and the "antidyskinetic" drugs, oxiperomide and tiapride. Psychopharmacology (Berl) . 1981;75 (3) :254-7.|[3]Skafi N, et al. Phospholipase D: A new mediator during high phosphate-induced vascular calcification associated with chronic kidney disease. J Cell Physiol. 2019 Apr;234 (4) :4825-4839.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742056-100 1x 100 µL
CD7 (T-Cell Leukemia Marker) (CD7/3737), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
HA723320 100 µL
Human ICOSLG/B7-H2/CD275 Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details